
This week we get into treatment. Building on Part 1's (episode 158: https://www.thefellowoncall.com/tfocpodcast/hncintro) workup and staging, we walk through three cases to highlight the important distinguishing details: an oral cavity cancer, a locally advanced oropharynx cancer, and a larynx cancer.Content: - Approach to locoregional oral, oropharynx, and larynx cancers - How we arrived at the current dosing paradigms for chemotherapy for chemoRT- Is there a role for induction therapy?- What are the data for immunotherapy in this space? - High risk factors and why they matter**This episode is sponsored by Primum! Sign up for your free account at primum.co/fellows** Want to review the show notes for this episode and others? Check out our website. Love what you hear? Tell a friend and leave a review on our podcast streaming platforms!Twitter: @TheFellowOnCallInstagram: @TheFellowOnCallListen in on: Apple Podcast, Spotify, and Youtube
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.

Episode 165: CLL Updates Series, Pt. 2 – Relapsed/Refractory in 2026

Episode 164: CLL Updates Series, Pt. 1 – Frontline Therapy in 2026

Episode 163: Head and Neck Cancer Series, Pt. 5 – Recurrent, Relapsed, and Metastatic Disease

Episode 162: Head and Neck Cancer Series, Pt. 4 – Discussion with Radiation Oncology
Free AI-powered recaps of The Fellow on Call: The Heme/Onc Podcast and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.